文献速递慢病管理预防保健、筛查与疫苗

HOME BP 数字干预改善基层高血压控制:随机对照试验

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial.
PubMed 文献 · BMJ · 2021-01-19

HOME BP 试验纳入英国 76 家全科诊所中 622 例治疗但控制不佳的高血压患者(>140/90 mm Hg),随机分为数字干预组(自我监测血压+数字化反馈与指导)和常规照护组。一年后干预组收缩压较常规组多降低 3.4 mm Hg(95%CI -6.1 至 -0.8),舒张压差异无统计学意义,增量成本效益比低。

要点

  • 数字干预组一年后收缩压较常规组多降 3.4 mm Hg(95%CI -6.1 至 -0.8)
  • 舒张压差异 -0.5 mm Hg(95%CI -1.9 至 0.9),无统计学意义
  • 每降低 1 mm Hg 的增量成本效益比为 £11(95%CI £6 至 £29)

核心结论

  • 在基层高血压管理中使用自我监测血压结合数字干预,一年后收缩压控制优于常规照护,且增量成本低。

研究设计与样本

  • 非盲随机对照试验,在英国 76 家全科诊所开展,纳入 622 例治疗但控制不佳(>140/90 mm Hg)且可上网的高血压患者。
  • 采用最小化算法随机分为数字干预组(305 例)和常规照护组(317 例),主要终点为一年后收缩压(第二、三次读数均值)差异,并对缺失值进行多重插补。

主要发现

  • 一年后 552 例(88.6%)有数据,其余 70 例(11.4%)采用插补。
  • 干预组血压从 151.7/86.4 降至 138.4/80.2 mm Hg,常规组从 151.6/85.3 降至 141.8/79.8 mm Hg。
  • 收缩压平均差异 -3.4 mm Hg(95%CI -6.1 至 -0.8),舒张压平均差异 -0.5 mm Hg(95%CI -1.9 至 0.9)。
  • 完整案例分析结果与主分析相当,两组不良事件相似。
  • 试验内成本显示每降低 1 mm Hg 的增量成本效益比为 £11(95%CI £6 至 £29)。

关键数值与推荐

  • 干预组接受血压自我监测及数字干预,向患者和专业人员反馈血压结果,并提供可选的生活方式建议和激励支持。
  • 高血压、糖尿病及 80 岁及以上人群的目标血压遵循英国国家指南。

临床怎么用

  • 在基层高血压管理中可考虑将自我监测血压与数字反馈干预整合入临床工作流程。
  • 实施时需考虑无法使用数字工具的人群(数字排斥)。

局限性

  • 研究为非盲设计,但主要终点采用自动化判定。
  • 部分参与者(11.4%)缺失主要终点数据,采用多重插补处理。
  • 研究在英国全科诊所开展,外推需考虑医疗体系差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The HOME BP (Home and Online Management and Evaluation of Blood Pressure) trial aimed to test a digital intervention for hypertension management in primary care by combining self-monitoring of blood pressure with guided self-management. DESIGN: Unmasked randomised controlled trial with automated ascertainment of primary endpoint. SETTING: 76 general practices in the United Kingdom. PARTICIPANTS: 622 people with treated but poorly controlled hypertension (>140/90 mm Hg) and access to the internet. INTERVENTIONS: Participants were randomised by using a minimisation algorithm to self-monitoring of blood pressure with a digital intervention (305 participants) or usual care (routine hypertension care, with appointments and drug changes made at the discretion of the general practitioner; 317 participants). The digital intervention provided feedback of blood pressure results to patients and professionals with optional lifestyle advice and motivational support. Target blood pressure for hypertension, diabetes, and people aged 80 or older followed UK national guidelines. MAIN OUTCOME MEASURES: The primary outcome was the difference in systolic blood pressure (mean of second and third readings) after one year, adjusted for baseline blood pressure, blood pressure target, age, and practice, with multiple imputation for missing values. RESULTS: After one year, data were available from 552 participants (88.6%) with imputation for the remaining 70 participants (11.4%). Mean blood pressure dropped from 151.7/86.4 to 138.4/80.2 mm Hg in the intervention group and from 151.6/85.3 to 141.8/79.8 mm Hg in the usual care group, giving a mean difference in systolic blood pressure of -3.4 mm Hg (95% confidence interval -6.1 to -0.8 mm Hg) and a mean difference in diastolic blood pressure of -0.5 mm Hg (-1.9 to 0.9 mm Hg). Results were comparable in the complete case analysis and adverse effects were similar between groups. Within trial costs showed an incremental cost effectiveness ratio of £11 ($15, €12; 95% confidence interval £6 to £29) per mm Hg reduction. CONCLUSIONS: The HOME BP digital intervention for the management of hypertension by using self-monitored blood pressure led to better control of systolic blood pressure after one year than usual care, with low incremental costs. Implementation in primary care will require integration into clinical workflows and consideration of people who are digitally excluded. TRIAL REGISTRATION: ISRCTN13790648.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. McManus RJ, Little P, Stuart B, et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ. 2021. PMID: 33468518. doi:10.1136/bmj.m4858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。